October Pharma S.A.E (EGX: OCPH)

October Pharma S.A.E Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,299	1,200	1,200	978	600	396
Market Cap Growth	22.71%	0%	22.68%	63.02%	51.52%	3.61%
Enterprise Value	1,806	1,518	1,257	1,193	853	635
Last Close Price	108.23	97.50	97.50	77.49	46.11	29.97
PE Ratio	12.12	7.78	10.29	7.76	6.27	10.63
PS Ratio	1.87	1.19	1.65	1.49	1.10	0.76
PB Ratio	2.00	2.04	2.82	2.88	2.36	2.19
P/TBV Ratio	2.61	2.41	3.67	4.18	4.25	6.59
P/FCF Ratio	21.02	10.21	-	4.03	12.59	6.30
P/OCF Ratio	14.88	7.85	-	3.73	11.26	4.12
EV/Sales Ratio	1.51	1.50	1.73	1.82	1.57	1.21
EV/EBITDA Ratio	1.38	4.61	5.68	5.52	5.20	5.52
EV/EBIT Ratio	1.40	4.94	6.31	6.10	5.88	6.45
EV/FCF Ratio	29.23	12.91	-	4.92	17.90	10.11
Debt / Equity Ratio	0.86	0.55	0.76	0.22	0.98	1.43
Debt / EBITDA Ratio	0.42	0.98	1.46	0.34	1.52	2.24
Debt / FCF Ratio	8.98	2.76	-	0.31	5.21	4.10
Asset Turnover	0.93	0.97	0.97	1.13	0.95	0.96
Inventory Turnover	-	2.45	1.78	2.15	2.55	3.36
Quick Ratio	0.40	0.56	0.36	0.75	0.31	0.33
Current Ratio	1.58	1.82	1.54	2.17	1.37	1.12
Return on Equity (ROE)	36.43%	35.89%	34.18%	40.38%	40.64%	20.13%
Return on Assets (ROA)	62.69%	18.38%	16.57%	21.09%	15.84%	11.34%
Return on Capital (ROIC)	77.11%	23.10%	21.43%	26.69%	19.29%	13.62%
Earnings Yield	8.25%	15.18%	10.90%	12.25%	14.71%	8.54%
FCF Yield	4.76%	9.80%	-15.42%	24.79%	7.94%	15.87%
Dividend Yield	2.31%	2.56%	-	-	3.25%	-
Payout Ratio	25.81%	9.86%	34.16%	28.54%	16.83%	29.34%
Total Shareholder Return	57.82%	2.56%	-	-	3.25%	-

Source: S&P Capital IQ. Standard template. Financial Sources.